3-DAY TREATMENT OF TYPHOID-FEVER WITH 2 DIFFERENT DOSES OF CEFTRIAXONE, COMPARED TO 14-DAY THERAPY WITH CHLORAMPHENICOL - A RANDOMIZED TRIAL

被引:34
作者
LASSERRE, R [1 ]
SANGALANG, RP [1 ]
SANTIAGO, L [1 ]
机构
[1] SAN LAZARO HOSP,MANILA,PHILIPPINES
关键词
D O I
10.1093/jac/28.5.765
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fifty-nine adult Filipino patients suffering from typhoid fever documented by blood culture were randomly allocated to one of three different drug regimens. Nineteen patients received 3 g ceftriaxone iv once daily for three days. Twenty patients received 4 g ceftriaxone iv once daily for three days and 20 patients received oral chloramphenicol 3 g daily in divided doses for two days followed by 2 g daily for 12 days. Eighteen patients were cured (95%) with 3 g of ceftriaxone for three days. All patients receiving 4 g ceftriaxone per day for three days or chloramphenicol for 14 days were cured. In the ceftriaxone groups two patients developed typhoid fever 30 and 45 days respectively after completion of treatment and one further patient had evidence of reinfection. Three patients relapsed within 15 to 17 days in the chloramphenicol group.Fever subsided in most patients between six and eight days, with three patients having a prolonged and moderate fever for 11 days in the ceftriaxone groups.This study suggests that a short treatment of three days of typhoid fever with ceftriaxone (3 or 4 g once daily) is adequate and not hazardous as far as relapses are concerned. © 1991, by The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:765 / 772
页数:8
相关论文
共 21 条
[1]  
AUVERGNAT JC, 1985, MED MALADIES INFECT, V8, P455
[2]  
BARROS MA, 1985, RECENT ADV CHEMOTHER, V3, P1998
[3]   ANTIBIOTICS AND ABERDEEN TYPHOID OUTBREAK IN 1964 [J].
BRODIE, J .
JOURNAL OF HYGIENE, 1976, 76 (02) :191-203
[4]   CHLORAMPHENICOL-RESISTANT TYPHOID-FEVER IN VIETNAM ASSOCIATED WITH-R FACTOR [J].
BUTLER, T ;
ARNOLD, K ;
LINH, NN ;
POLLACK, M .
LANCET, 1973, 2 (7836) :983-985
[5]   INVITRO SUSCEPTIBILITY OF SALMONELLA TO VARIOUS ANTI-MICROBIAL AGENTS, INCLUDING A NEW CEPHALOSPORIN, RO 13-9904 [J].
CHAU, PY ;
NG, WS ;
LING, J ;
ARNOLD, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (01) :8-11
[6]   SALMONELLA-TYPHI INVIVO ACQUIRES RESISTANCE TO BOTH CHLORAMPHENICOL AND CO-TRIMOXAZOLE [J].
DATTA, N ;
RICHARDS, H ;
DATTA, C .
LANCET, 1981, 1 (8231) :1181-1183
[7]  
Delia S, 1968, Policlinico Prat, V75, P786
[8]   RANDOMIZED TREATMENT OF PATIENTS WITH TYPHOID-FEVER BY USING CEFTRIAXONE OR CHLORAMPHENICOL [J].
ISLAM, A ;
BUTLER, T ;
NATH, SK ;
ALAM, NH ;
STOECKEL, K ;
HOUSER, HB ;
SMITH, AL .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04) :742-747
[9]  
KINNEAR TWG, 1971, MANAGEMENT TREATMENT, P575
[10]   AUTORADIOGRAPHIC EVIDENCE FOR PENETRATION OF H-3 CEFTRIAXONE (ROCEPHIN) INTO CELLS OF SPLEEN, LIVER AND KIDNEY OF MICE [J].
KUHN, H ;
ANGEHRN, P ;
HAVAS, L .
CHEMOTHERAPY, 1986, 32 (02) :102-112